tiprankstipranks
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP

NRX Pharmaceuticals (NRXP) Stock Investors

262 Followers
Based on 728,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NRXP
On average, investors allocate 0.00% of their portfolios to NRXP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NRXP

1.3%
Last 7
Days
7.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NRXP, out of 728,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NRXP Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.97%
$6.13
Increased
0.56%
$7.01
Opened
1.79%
$4.38
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in NRXP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NRXP Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
3.92%
-0.91%
-7.35%
668.91M
Consumer Cyclical
DraftKings
7.19%
-1.26%
-3.57%
37.89B
Consumer Cyclical
AMC Entertainment
5.42%
-1.38%
-6.90%
651.10M
Communication Services
Riot Platforms
4.74%
-1.51%
+0.37%
2.17B
Financial
Marathon Digital Holdings
5.39%
-0.26%
-3.45%
4.28B
Financial
Lucid Group
5.42%
-1.15%
-6.55%
5.59B
Consumer Cyclical
Blink Charging Co
5.07%
-1.37%
-6.36%
231.28M
Industrials
Block
4.49%
-1.08%
-7.00%
45.25B
Technology
Plug Power
4.90%
-0.92%
-6.51%
1.95B
Industrials
Merck & Company
4.12%
-0.04%
-0.41%
319.59B
Healthcare
Based on the activity of 728,786 active portfolios
Open your Smart Portfolio

NRXP Investor Analysis

NRXP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
5.0%
of NRXP holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
NRXP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
70.0%
of NRXP holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
NRXP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
25.0%
of NRXP holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of NRXP stock investors
See who invests in NRXP according to age group and performance.

FAQ

How many retail Investors hold NRXP?
<0.1% of TipRanks' retail investors hold NRXP in their portfolios.
    What is NRXP Investor Sentiment?
    NRXP’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of NRXP in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of NRXP in the last 7 days.
        What percentage of retail investors changed their holding of NRXP in the last 30 days?
        ▼ 7.0% of TipRanks' retail investors changed their holding of NRXP in the last 30 days.
          What is the average age of retail investors who hold NRXP?
          The average age of NRXP Holders is between 35–55.
            What other stocks have NRXP investors also bought?
            NRXP Investors also bought CHPT, DKNG, AMC, RIOT, MARA, LCID, BLNK, SQ, PLUG, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis